Telemus Capital’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-8,000
Closed -$1.78M 458
2020
Q3
$1.78M Hold
8,000
0.13% 136
2020
Q2
$743K Buy
8,000
+5,000
+167% +$417K 0.06% 217
2020
Q1
$307K Buy
+3,000
New +$192K 0.03% 308

Telemus Capital's MYOK Position: Q4 2020 in Review

Telemus Capital sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 8,000 shares — an estimated $1.78M sold.

Telemus Capital first reported a position in MYOK in Q1 2020 and held it in 3 quarters. The position peaked at $1.78M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Telemus Capital reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Telemus Capital sold 8,000 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $1.78M.
  • Telemus Capital first reported a position in MyoKardia, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
  • Telemus Capital's MyoKardia, Inc. Common Stock position peaked at $1.78M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Telemus Capital's 13F filing for Q4 2020, filed 28 Jan 2021.